To better understand the future of telehealth, it is important to understand what the costs look like over time and whether telehealth offers advantages in cutting healthcare costs overall.
Part three of this series discusses the key defenses available to each element of a lawsuit against providers and labs.
A Q&A with MedCrypt’s Axel Wirth sheds light on urgent problems that the medtech industry is facing regarding device security, but assures us that the sky is not falling.
New health-related data is arriving almost daily. Making sense of it all is a huge challenge.
Companies developing technologies that integrate AI need to consider regulatory concerns, community demographics, fitting into existing workflows, technical proficiency of both the hospital personnel and consumers.
Without even factoring in the effects of COVID-19, ransomware attacks against healthcare providers have significantly increased. We must be ready to detect and respond to them before damage can be done.
Analysts expect 2020 to be a busy year for M&A activity.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
The adoption of accurate non-invasive measures of liver health at the point of care is critical.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.